Get Real Time Here
| Day Range1.140 - 1.190 | 52 Wk Range0.684 - 2.120 | Open / Close1.190 / - | Float / Outstanding180.713M / 256.667M |
| Vol / Avg.77.384K / 497.016K | Mkt Cap299.017M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float180.713M | EPS-0.310 |
Outlook Therapeutics Stock (NASDAQ:OTLK), Quotes and News Summary
Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.
| Day Range1.140 - 1.190 | 52 Wk Range0.684 - 2.120 | Open / Close1.190 / - | Float / Outstanding180.713M / 256.667M |
| Vol / Avg.77.384K / 497.016K | Mkt Cap299.017M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float180.713M | EPS-0.310 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-13 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.060 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Outlook Therapeutics (OTLK) stock?
You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.
Who are Outlook Therapeutics's (OTLK) competitors?
Other companies in Outlook Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Innate Pharma (NASDAQ:IPHA), Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV) and Precigen (NASDAQ:PGEN).
What is the target price for Outlook Therapeutics (OTLK) stock?
The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on Friday, January 6, 2023. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 329.18% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Outlook Therapeutics (OTLK)?
The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $1.165 last updated Today at January 31, 2023 at 5:59 PM UTC.
Does Outlook Therapeutics (OTLK) pay a dividend?
There are no upcoming dividends for Outlook Therapeutics.
When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?
Outlook Therapeutics’s Q1 earnings are confirmed for Monday, February 13, 2023.
Is Outlook Therapeutics (OTLK) going to split?
There is no upcoming split for Outlook Therapeutics.
What sector and industry does Outlook Therapeutics (OTLK) operate in?
Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Outlook Therapeutics Stock (NASDAQ:OTLK), Quotes and News Summary
Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.
| Day Range1.140 - 1.190 | 52 Wk Range0.684 - 2.120 | Open / Close1.190 / - | Float / Outstanding180.713M / 256.667M |
| Vol / Avg.77.384K / 497.016K | Mkt Cap299.017M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float180.713M | EPS-0.310 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-13 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.060 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Outlook Therapeutics (OTLK) stock?
You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.
Who are Outlook Therapeutics's (OTLK) competitors?
Other companies in Outlook Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Innate Pharma (NASDAQ:IPHA), Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV) and Precigen (NASDAQ:PGEN).
What is the target price for Outlook Therapeutics (OTLK) stock?
The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on Friday, January 6, 2023. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 329.18% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Outlook Therapeutics (OTLK)?
The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $1.165 last updated Today at January 31, 2023 at 5:59 PM UTC.
Does Outlook Therapeutics (OTLK) pay a dividend?
There are no upcoming dividends for Outlook Therapeutics.
When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?
Outlook Therapeutics’s Q1 earnings are confirmed for Monday, February 13, 2023.
Is Outlook Therapeutics (OTLK) going to split?
There is no upcoming split for Outlook Therapeutics.
What sector and industry does Outlook Therapeutics (OTLK) operate in?
Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Outlook Therapeutics Stock (NASDAQ:OTLK), Quotes and News Summary
Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.
| Day Range1.140 - 1.190 | 52 Wk Range0.684 - 2.120 | Open / Close1.190 / - | Float / Outstanding180.713M / 256.667M |
| Vol / Avg.77.384K / 497.016K | Mkt Cap299.017M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float180.713M | EPS-0.310 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-13 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.060 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Outlook Therapeutics (OTLK) stock?
You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.
Who are Outlook Therapeutics's (OTLK) competitors?
Other companies in Outlook Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Innate Pharma (NASDAQ:IPHA), Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV) and Precigen (NASDAQ:PGEN).
What is the target price for Outlook Therapeutics (OTLK) stock?
The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on Friday, January 6, 2023. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 329.18% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Outlook Therapeutics (OTLK)?
The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $1.165 last updated Today at January 31, 2023 at 5:59 PM UTC.
Does Outlook Therapeutics (OTLK) pay a dividend?
There are no upcoming dividends for Outlook Therapeutics.
When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?
Outlook Therapeutics’s Q1 earnings are confirmed for Monday, February 13, 2023.
Is Outlook Therapeutics (OTLK) going to split?
There is no upcoming split for Outlook Therapeutics.
What sector and industry does Outlook Therapeutics (OTLK) operate in?
Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Outlook Therapeutics Stock (NASDAQ:OTLK), Quotes and News Summary
Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.
| Day Range1.140 - 1.190 | 52 Wk Range0.684 - 2.120 | Open / Close1.190 / - | Float / Outstanding180.713M / 256.667M |
| Vol / Avg.77.384K / 497.016K | Mkt Cap299.017M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float180.713M | EPS-0.310 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-13 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.060 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Outlook Therapeutics (OTLK) stock?
You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.
Who are Outlook Therapeutics's (OTLK) competitors?
Other companies in Outlook Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Innate Pharma (NASDAQ:IPHA), Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV) and Precigen (NASDAQ:PGEN).
What is the target price for Outlook Therapeutics (OTLK) stock?
The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on Friday, January 6, 2023. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 329.18% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Outlook Therapeutics (OTLK)?
The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $1.165 last updated Today at January 31, 2023 at 5:59 PM UTC.
Does Outlook Therapeutics (OTLK) pay a dividend?
There are no upcoming dividends for Outlook Therapeutics.
When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?
Outlook Therapeutics’s Q1 earnings are confirmed for Monday, February 13, 2023.
Is Outlook Therapeutics (OTLK) going to split?
There is no upcoming split for Outlook Therapeutics.
What sector and industry does Outlook Therapeutics (OTLK) operate in?
Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Outlook Therapeutics Stock (NASDAQ:OTLK), Quotes and News Summary
Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.
| Day Range1.140 - 1.190 | 52 Wk Range0.684 - 2.120 | Open / Close1.190 / - | Float / Outstanding180.713M / 256.667M |
| Vol / Avg.77.384K / 497.016K | Mkt Cap299.017M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float180.713M | EPS-0.310 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-13 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.060 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Outlook Therapeutics (OTLK) stock?
You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.
Who are Outlook Therapeutics's (OTLK) competitors?
Other companies in Outlook Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Innate Pharma (NASDAQ:IPHA), Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV) and Precigen (NASDAQ:PGEN).
What is the target price for Outlook Therapeutics (OTLK) stock?
The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on Friday, January 6, 2023. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 329.18% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Outlook Therapeutics (OTLK)?
The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $1.165 last updated Today at January 31, 2023 at 5:59 PM UTC.
Does Outlook Therapeutics (OTLK) pay a dividend?
There are no upcoming dividends for Outlook Therapeutics.
When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?
Outlook Therapeutics’s Q1 earnings are confirmed for Monday, February 13, 2023.
Is Outlook Therapeutics (OTLK) going to split?
There is no upcoming split for Outlook Therapeutics.
What sector and industry does Outlook Therapeutics (OTLK) operate in?
Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Outlook Therapeutics Stock (NASDAQ:OTLK), Quotes and News Summary
Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.
| Day Range1.140 - 1.190 | 52 Wk Range0.684 - 2.120 | Open / Close1.190 / - | Float / Outstanding180.713M / 256.667M |
| Vol / Avg.77.384K / 497.016K | Mkt Cap299.017M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float180.713M | EPS-0.310 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-13 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.060 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Outlook Therapeutics (OTLK) stock?
You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.
Who are Outlook Therapeutics's (OTLK) competitors?
Other companies in Outlook Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Innate Pharma (NASDAQ:IPHA), Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV) and Precigen (NASDAQ:PGEN).
What is the target price for Outlook Therapeutics (OTLK) stock?
The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on Friday, January 6, 2023. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 329.18% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Outlook Therapeutics (OTLK)?
The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $1.165 last updated Today at January 31, 2023 at 5:59 PM UTC.
Does Outlook Therapeutics (OTLK) pay a dividend?
There are no upcoming dividends for Outlook Therapeutics.
When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?
Outlook Therapeutics’s Q1 earnings are confirmed for Monday, February 13, 2023.
Is Outlook Therapeutics (OTLK) going to split?
There is no upcoming split for Outlook Therapeutics.
What sector and industry does Outlook Therapeutics (OTLK) operate in?
Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Outlook Therapeutics Stock (NASDAQ:OTLK), Quotes and News Summary
Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.
| Day Range1.140 - 1.190 | 52 Wk Range0.684 - 2.120 | Open / Close1.190 / - | Float / Outstanding180.713M / 256.667M |
| Vol / Avg.77.384K / 497.016K | Mkt Cap299.017M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float180.713M | EPS-0.310 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-13 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.060 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Outlook Therapeutics (OTLK) stock?
You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.
Who are Outlook Therapeutics's (OTLK) competitors?
Other companies in Outlook Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Innate Pharma (NASDAQ:IPHA), Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV) and Precigen (NASDAQ:PGEN).
What is the target price for Outlook Therapeutics (OTLK) stock?
The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on Friday, January 6, 2023. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 329.18% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Outlook Therapeutics (OTLK)?
The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $1.165 last updated Today at January 31, 2023 at 5:59 PM UTC.
Does Outlook Therapeutics (OTLK) pay a dividend?
There are no upcoming dividends for Outlook Therapeutics.
When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?
Outlook Therapeutics’s Q1 earnings are confirmed for Monday, February 13, 2023.
Is Outlook Therapeutics (OTLK) going to split?
There is no upcoming split for Outlook Therapeutics.
What sector and industry does Outlook Therapeutics (OTLK) operate in?
Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Outlook Therapeutics Stock (NASDAQ:OTLK), Quotes and News Summary
Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.
| Day Range1.140 - 1.190 | 52 Wk Range0.684 - 2.120 | Open / Close1.190 / - | Float / Outstanding180.713M / 256.667M |
| Vol / Avg.77.384K / 497.016K | Mkt Cap299.017M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float180.713M | EPS-0.310 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-13 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.060 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Outlook Therapeutics (OTLK) stock?
You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.
Who are Outlook Therapeutics's (OTLK) competitors?
Other companies in Outlook Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Innate Pharma (NASDAQ:IPHA), Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV) and Precigen (NASDAQ:PGEN).
What is the target price for Outlook Therapeutics (OTLK) stock?
The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on Friday, January 6, 2023. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 329.18% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Outlook Therapeutics (OTLK)?
The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $1.165 last updated Today at January 31, 2023 at 5:59 PM UTC.
Does Outlook Therapeutics (OTLK) pay a dividend?
There are no upcoming dividends for Outlook Therapeutics.
When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?
Outlook Therapeutics’s Q1 earnings are confirmed for Monday, February 13, 2023.
Is Outlook Therapeutics (OTLK) going to split?
There is no upcoming split for Outlook Therapeutics.
What sector and industry does Outlook Therapeutics (OTLK) operate in?
Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Outlook Therapeutics Stock (NASDAQ:OTLK), Quotes and News Summary
Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.
| Day Range1.140 - 1.190 | 52 Wk Range0.684 - 2.120 | Open / Close1.190 / - | Float / Outstanding180.713M / 256.667M |
| Vol / Avg.77.384K / 497.016K | Mkt Cap299.017M | P/E- | 50d Avg. Price1.050 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float180.713M | EPS-0.310 |
Earnings
see more| Q1 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-02-13 | ||||||
| REV | |||||||
| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.060 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Outlook Therapeutics (OTLK) stock?
You can purchase shares of Outlook Therapeutics (NASDAQ: OTLK) through any online brokerage.
Who are Outlook Therapeutics's (OTLK) competitors?
Other companies in Outlook Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Innate Pharma (NASDAQ:IPHA), Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV) and Precigen (NASDAQ:PGEN).
What is the target price for Outlook Therapeutics (OTLK) stock?
The latest price target for Outlook Therapeutics (NASDAQ: OTLK) was reported by HC Wainwright & Co. on Friday, January 6, 2023. The analyst firm set a price target for 5.00 expecting OTLK to rise to within 12 months (a possible 329.18% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Outlook Therapeutics (OTLK)?
The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $1.165 last updated Today at January 31, 2023 at 5:59 PM UTC.
Does Outlook Therapeutics (OTLK) pay a dividend?
There are no upcoming dividends for Outlook Therapeutics.
When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?
Outlook Therapeutics’s Q1 earnings are confirmed for Monday, February 13, 2023.
Is Outlook Therapeutics (OTLK) going to split?
There is no upcoming split for Outlook Therapeutics.
What sector and industry does Outlook Therapeutics (OTLK) operate in?
Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.